Xiaoqin Zhu
Guangzhou, 511436, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
RVG-targeted extracellular vesicles loaded with echinatin attenuate dopaminergic neurodegeneration via the IGF-2/PI3K/Akt pathway in Parkinson's disease mice.
Journal: Journal of nanobiotechnology
Published: October 13, 2025
A Novel H2S Donor Suppresses Pilocarpine-Induced Seizures Through TREM2 Signaling.
Journal: Neurochemical research
Published: September 15, 2025
Astrocyte-microglia IL-3-IL-3Rα signaling drives JAK2/STAT5-dependent neuroinflammation and neurodegeneration after status epilepticus.
Journal: Experimental brain research
Published: August 28, 2025
The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis.
Journal: NPJ Parkinson's disease
Published: August 26, 2025
In Situ Slow-Release Hydrogen Sulfide Therapeutics for Advanced Disease Treatments.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 15, 2024
Corrigendum: Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease.
Journal: Frontiers in aging neuroscience
Published: October 05, 2024
CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson's disease.
Journal: Neural regeneration research
Published: July 25, 2023
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease.
Journal: Frontiers in aging neuroscience
Published: October 23, 2022
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease.
Journal: Chinese medical journal
Published: July 13, 2022
A Novel Hydrogen Sulfide Donor Reduces Pilocarpine-Induced Status Epilepticus and Regulates Microglial Inflammatory Profile.
Journal: Frontiers in cellular neuroscience
Published: September 21, 2021
Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson's Disease.
Journal: Frontiers in aging neuroscience
Published: August 04, 2021
Last Updated: 09/26/2026